A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT02162836 · COMPLETED
Trial details
- NCT number
- NCT02162836
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-27
- Primary completion
- 2019-05-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.